Evidence map›Paper›PMID 40080808›Full record

ArticleJMIR AI2025

Creation of Scientific Response Documents for Addressing Product Medical Information Inquiries: Mixed Method Approach Using Artificial Intelligence.

Jerry Lau, Shivani Bisht, Robert Horton, Annamaria Crisan, John Jones, Sandeep Gantotti, Evelyn Hermes-DeSantis

Abstract read
In one paragraph

Article in JMIR AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jerry LauphactMI, Gainesville, FL, United States.ORCID https://orcid.org/0009-0005-1756-785X
Shivani BishtEli Lilly and Company, Bangalore, India.ORCID https://orcid.org/0009-0008-4360-8485
Robert HortonWin-Vector Labs, Marin City, CA, United States.ORCID https://orcid.org/0000-0001-7305-354X
Annamaria CrisanPfizer, Montreal, QC, Canada.ORCID https://orcid.org/0009-0001-9218-354X
John JonesphactMI, Gainesville, FL, United States.ORCID https://orcid.org/0009-0002-2786-3837
Sandeep GantottiIndegene Limited, Bangalore, India.ORCID https://orcid.org/0000-0002-3091-0086
Evelyn Hermes-DeSantisphactMI, Gainesville, FL, United States.ORCID https://orcid.org/0000-0001-5658-3899

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPharmaceutical manufacturers address health care professionals' information needs through scientific response documents (SRDs), offering evidence-based answers to medication and disease state questions. Medical information departments, staffed by medical experts, develop SRDs that provide concise summaries consisting of relevant background information, search strategies, clinical data, and balanced references. With an escalating demand for SRDs and the increasing complexity of therapies, medical information departments are exploring advanced technologies and artificial intelligence (AI) tools like large language models (LLMs) to streamline content development. While AI and LLMs show promise in generating draft responses, a synergistic approach combining an LLM with traditional machine learning classifiers in a series of human-supervised and -curated steps could help address limitations, including hallucinations. This will ensure accuracy, context, traceability, and accountability in the development of the concise clinical data summaries of an SRD.

objectiveThis study aims to quantify the challenges of SRD development and develop a framework exploring the feasibility and value addition of integrating AI capabilities in the process of creating concise summaries for an SRD.

methodsTo measure the challenges in SRD development, a survey was conducted by phactMI, a nonprofit consortium of medical information leaders in the pharmaceutical industry, assessing aspects of SRD creation among its member companies. The survey collected data on the time and tediousness of various activities related to SRD development. Another working group, consisting of medical information professionals and data scientists, used AI to aid SRD authoring, focusing on data extraction and abstraction. They used logistic regression on semantic embedding features to train classification models and transformer-based summarization pipelines to generate concise summaries.

resultsOf the 33 companies surveyed, 64% (21/33) opened the survey, and 76% (16/21) of those responded. On average, medical information departments generate 614 new documents and update 1352 documents each year. Respondents considered paraphrasing scientific articles to be the most tedious and time-intensive task. In the project's second phase, sentence classification models showed the ability to accurately distinguish target categories with receiver operating characteristic scores ranging from 0.67 to 0.85 (all P<.001), allowing for accurate data extraction. For data abstraction, the comparison of the bilingual evaluation understudy (BLEU) score and semantic similarity in the paraphrased texts yielded different results among reviewers, with each preferring different trade-offs between these metrics.

conclusionsThis study establishes a framework for integrating LLM and machine learning into SRD development, supported by a pharmaceutical company survey emphasizing the challenges of paraphrasing content. While machine learning models show potential for section identification and content usability assessment in data extraction and abstraction, further optimization and research are essential before full-scale industry implementation. The working group's insights guide an AI-driven content analysis; address limitations; and advance efficient, precise, and responsive frameworks to assist with pharmaceutical SRD development.

Indexed as

accountabilityaccuracyAIartificial intelligencebenefitbiopharmaceuticalclinical datacontent analysiscontent generationcontent generatorcontextdevelopmentdocumentationfeasibilityGenerative Pre-trained TransformerGPTinformationlarge language modelLLMmachine learningmedical informationpharmaceuticalreferencescientific responsescientific response documentationSRDstrategysurveytraceability

Identifiers

PMID40080808
PMCPMC11950693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.